东诚药业: 半年报监事会决议公告

Group 1 - The sixth supervisory board meeting of Dongcheng Pharmaceutical Group was held, with all members ensuring the accuracy and completeness of the disclosed information [1] - The meeting reviewed and approved the 2025 semi-annual report and its summary, confirming that the report reflects the company's actual situation without any false records or misleading statements [1][2] - The voting results showed unanimous support with 3 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The meeting was conducted in accordance with legal regulations and the company's articles of association, with all three supervisors present [1] - The meeting was chaired by the chairman of the supervisory board, Mr. Liu Qinglin, and the company secretary, Mr. Liu Xiaojie, attended as an observer [1] - The full semi-annual report and its summary are available on various financial news platforms and the company's official website [2]